Clearside Biomedical, Inc.
US ˙ NasdaqGM ˙ US1850631045

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Clay Thorp. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Clay Thorp har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:CLSD / Clearside Biomedical, Inc. Director 176.141
US:PHAS / PhaseBio Pharmaceuticals Inc Director 36.693
US:VIGL / Vigil Neuroscience, Inc. Director 1.556.030
US:GTHX / G1 Therapeutics, Inc. 10% Owner 3.237.711
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Clay Thorp. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb CLSD / Clearside Biomedical, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i CLSD / Clearside Biomedical, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2025-02-24 CLSD Thorp Clay 15.000 0,9200 15.000 0,9200 13.800 28 1.0300 1.650 11,96
2023-09-25 CLSD Thorp Clay 10.000 0,8600 10.000 0,8600 8.600
2022-12-21 CLSD Thorp Clay 14.000 1,0190 14.000 1,0190 14.266
2018-12-06 CLSD Thorp Clay 8.000 1,3600 8.000 1,3600 10.880
2016-06-07 CLSD Hatteras Venture Advisors IV SBIC, LLC 414.286 7,0000 414.286 7,0000 2.900.002
2016-06-07 CLSD Hatteras Venture Advisors III, LLC 107.142 7,0000 107.142 7,0000 749.994
2016-06-07 CLSD Thorp Clay 785.714 7,0000 785.714 7,0000 5.499.998

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

CLSD / Clearside Biomedical, Inc. Insider Trades
Insidersalg CLSD / Clearside Biomedical, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i CLSD / Clearside Biomedical, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2018-05-18 CLSD Thorp Clay 61.139 13,1600 61.139 13,1600 804.589 217 1.0000 -743.450 -92,40
2018-05-17 CLSD Thorp Clay 100.000 13,0300 100.000 13,0300 1.303.000
2018-03-23 CLSD Thorp Clay 5.231 12,0200 5.231 12,0200 62.877
2018-03-22 CLSD Thorp Clay 33.630 12,0700 33.630 12,0700 405.914
2018-03-21 CLSD Thorp Clay 100.000 12,2700 100.000 12,2700 1.227.000
2017-01-19 CLSD Hatteras Venture Advisors IV SBIC, LLC 7.592 8,2200 7.592 8,2200 62.406
2017-01-19 CLSD Hatteras Venture Advisors III, LLC 6.478 8,2200 6.478 8,2200 53.249
2017-01-18 CLSD Hatteras Venture Advisors IV SBIC, LLC 12.258 8,6400 12.258 8,6400 105.909
2017-01-18 CLSD Hatteras Venture Advisors III, LLC 10.457 8,6400 10.457 8,6400 90.348
2017-01-17 CLSD Hatteras Venture Advisors IV SBIC, LLC 9.806 8,9200 9.806 8,9200 87.470
2017-01-17 CLSD Hatteras Venture Advisors III, LLC 8.366 8,9200 8.366 8,9200 74.625
2016-06-07 CLSD Hatteras Venture Advisors IV SBIC, LLC 69 7,0000 69 7,0000 483
2016-06-07 CLSD Hatteras Venture Advisors III, LLC 69 7,0000 69 7,0000 483
2016-06-07 CLSD Thorp Clay 138 7,0000 138 7,0000 966

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

CLSD / Clearside Biomedical, Inc. Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Clay Thorp som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2025-02-24 2025-02-24 4 CLSD Clearside Biomedical, Inc.
Common Stock
P - Purchase 15.000 176.141 9,31 0,92 13.800 162.050
2023-09-25 2023-09-25 4 CLSD Clearside Biomedical, Inc.
Common Stock
P - Purchase 10.000 40.522 32,76 0,86 8.600 34.849
2023-05-19 2023-05-19 4 PHAS PhaseBio Pharmaceuticals Inc
Common Stock
M - Exercise 3.750 36.693 11,38
2022-12-21 2022-12-21 4 CLSD Clearside Biomedical, Inc.
Common Stock
P - Purchase 14.000 30.522 84,74 1,02 14.266 31.102
2022-12-19 2021-02-10 4/A CLSD Clearside Biomedical, Inc.
Common Stock
S - Sale X -32.873 4.951.547 -0,66 4,43 -145.627 21.935.353
2022-12-19 2022-12-15 4 CLSD Clearside Biomedical, Inc.
Common Stock
J - Other 8.522 16.522 106,52
2022-12-19 2022-12-15 4 CLSD Clearside Biomedical, Inc.
Common Stock
J - Other -1.406.507 3.545.040 -28,41
2022-05-20 2022-05-19 4 PHAS PhaseBio Pharmaceuticals Inc
Restricted Stock Units
A - Award 3.750 3.750
2022-05-20 2022-05-19 4 PHAS PhaseBio Pharmaceuticals Inc
Non-employee Director Stock Option (right to buy)
A - Award 17.500 17.500
2022-05-17 2022-05-17 4 VIGL Vigil Neuroscience, Inc.
Common Stock
P - Purchase 14.893 1.556.030 0,97 2,97 44.189 4.616.897
2022-05-17 2022-05-16 4 VIGL Vigil Neuroscience, Inc.
Common Stock
P - Purchase 21.802 1.541.137 1,43 2,76 60.221 4.256.929
2022-03-28 2022-03-28 4 VIGL Vigil Neuroscience, Inc.
Common Stock
P - Purchase 3.000 3.000 7,20 21.604 21.604
2022-01-11 2022-01-11 4 VIGL Vigil Neuroscience, Inc.
Series B Preferred Stock
C - Conversion -926.506 0 -100,00
2022-01-11 2022-01-11 4 VIGL Vigil Neuroscience, Inc.
Series A Preferred Stock
C - Conversion -2.552.021 0 -100,00
2022-01-11 2022-01-11 4 VIGL Vigil Neuroscience, Inc.
Common Stock
P - Purchase 265.000 1.519.335 21,13 14,00 3.710.000 21.270.690
2022-01-11 2022-01-11 4 VIGL Vigil Neuroscience, Inc.
Common Stock
C - Conversion 1.254.335 1.254.335
2021-08-18 2021-08-18 4 PHAS PhaseBio Pharmaceuticals Inc
Common Stock
P - Purchase 10.000 32.943 43,59 3,00 30.000 98.829
2021-06-11 2021-06-10 4 CLSD Clearside Biomedical, Inc.
Stock Option (right to buy)
A - Award 25.000 25.000
2021-06-04 2021-06-03 4 PHAS PhaseBio Pharmaceuticals Inc
Non-employee Director Stock Option (right to buy)
A - Award 14.000 14.000
2021-02-12 2021-02-10 4 CLSD Clearside Biomedical, Inc.
Common Stock
S - Sale X -32.873 3.433.521 -0,95 4,43 -145.627 15.210.498
2020-11-24 2020-11-24 4 PHAS PhaseBio Pharmaceuticals Inc
Common Stock
P - Purchase 2.000 22.943 9,55 3,50 7.000 80.300
2020-11-24 2020-11-23 4 PHAS PhaseBio Pharmaceuticals Inc
Common Stock
P - Purchase 3.000 20.943 16,72 3,67 11.010 76.861
2020-11-18 2020-11-16 4 PHAS PhaseBio Pharmaceuticals Inc
Common Stock
J - Other 10.586 15.432 218,45
2020-11-18 2020-11-16 4 PHAS PhaseBio Pharmaceuticals Inc
Common Stock
J - Other 2.144 17.943 13,57
2020-11-18 2020-11-16 4 PHAS PhaseBio Pharmaceuticals Inc
Common Stock
J - Other -52.397 0 -100,00
2020-06-19 2020-06-18 4 CLSD Clearside Biomedical, Inc.
Stock Option (right to buy)
A - Award 25.000 25.000
2020-06-05 2020-06-03 4 PHAS PhaseBio Pharmaceuticals Inc
Non-employee Director Stock Option (right to buy)
A - Award 16.000 16.000
2019-11-26 2019-11-22 4 CLSD Clearside Biomedical, Inc.
Common Stock
A - Award 1.518.026 4.984.420 43,79 1,05 1.599.999 5.253.579
2019-07-03 2019-07-01 4 PHAS PhaseBio Pharmaceuticals Inc
Common Stock
S - Sale X -459 415.959 -0,11 14,00 -6.426 5.823.426
2019-07-03 2019-07-01 4 PHAS PhaseBio Pharmaceuticals Inc
Common Stock
S - Sale X -255 52.397 -0,48 14,00 -3.570 733.558
2019-07-03 2019-07-01 4 PHAS PhaseBio Pharmaceuticals Inc
Common Stock
S - Sale X -180 162.890 -0,11 14,00 -2.520 2.280.460
2019-07-03 2019-07-01 4 PHAS PhaseBio Pharmaceuticals Inc
Common Stock
S - Sale X -2.014 1.818.638 -0,11 14,00 -28.196 25.460.932
2019-06-24 2019-06-20 4 CLSD Clearside Biomedical, Inc.
Stock Option (right to buy)
A - Award 20.000 20.000
2019-06-20 2019-06-18 4 PHAS PhaseBio Pharmaceuticals Inc
Common Stock
S - Sale X -63 416.418 -0,02 14,00 -882 5.829.852
2019-06-20 2019-06-18 4 PHAS PhaseBio Pharmaceuticals Inc
Common Stock
S - Sale X -35 52.655 -0,07 14,00 -490 737.170
2019-06-20 2019-06-18 4 PHAS PhaseBio Pharmaceuticals Inc
Common Stock
S - Sale X -25 163.074 -0,02 14,00 -350 2.283.036
2019-06-20 2019-06-18 4 PHAS PhaseBio Pharmaceuticals Inc
Common Stock
S - Sale X -277 1.820.656 -0,02 14,00 -3.878 25.489.184
2019-05-13 2019-05-09 4 PHAS PhaseBio Pharmaceuticals Inc
Non-employee Director Stock Option (right to buy)
A - Award 11.000 11.000
2019-03-01 2019-02-27 4 PHAS PhaseBio Pharmaceuticals Inc
Employee Stock Option (right to buy)
A - Award 36.000 36.000
2018-12-06 2018-12-04 4 PHAS PhaseBio Pharmaceuticals Inc
Common Stock
P - Purchase 4.000 15.799 33,90 3,13 12.520 49.451
2018-12-06 2018-12-06 4 CLSD Clearside Biomedical, Inc.
Common Stock
P - Purchase 8.000 8.000 1,36 10.880 10.880
2018-10-24 2018-10-22 4 PHAS PhaseBio Pharmaceuticals Inc
Series D Preferred Stock
C - Conversion -226.061 0 -100,00
2018-10-24 2018-10-22 4 PHAS PhaseBio Pharmaceuticals Inc
Series D Preferred Stock
C - Conversion -24.709 0 -100,00
2018-10-24 2018-10-22 4 PHAS PhaseBio Pharmaceuticals Inc
Series D Preferred Stock
C - Conversion -272.107 0 -100,00
2018-10-24 2018-10-22 4 PHAS PhaseBio Pharmaceuticals Inc
Series C-1 Preferred Stock
C - Conversion -40.420 0 -100,00
2018-10-24 2018-10-22 4 PHAS PhaseBio Pharmaceuticals Inc
Series C-1 Preferred Stock
C - Conversion -13.558 0 -100,00
2018-10-24 2018-10-22 4 PHAS PhaseBio Pharmaceuticals Inc
Series C-1 Preferred Stock
C - Conversion -149.320 0 -100,00
2018-10-24 2018-10-22 4 PHAS PhaseBio Pharmaceuticals Inc
Series B Preferred Stock
C - Conversion -94.874 0 -100,00
2018-10-24 2018-10-22 4 PHAS PhaseBio Pharmaceuticals Inc
Series B Preferred Stock
C - Conversion -1.044.764 0 -100,00
2018-10-24 2018-10-22 4 PHAS PhaseBio Pharmaceuticals Inc
Series AA Preferred Stock
C - Conversion -13.609 0 -100,00
2018-10-24 2018-10-22 4 PHAS PhaseBio Pharmaceuticals Inc
Series AA Preferred Stock
C - Conversion -174.699 0 -100,00
2018-10-24 2018-10-22 4 PHAS PhaseBio Pharmaceuticals Inc
Series 1 Preferred Stock
C - Conversion -4.846 0 -100,00
2018-10-24 2018-10-22 4 PHAS PhaseBio Pharmaceuticals Inc
Series 1 Preferred Stock
C - Conversion -3.862 0 -100,00
2018-10-24 2018-10-22 4 PHAS PhaseBio Pharmaceuticals Inc
Series 1 Preferred Stock
C - Conversion -42.530 0 -100,00
2018-10-24 2018-10-22 4 PHAS PhaseBio Pharmaceuticals Inc
Series 1 Preferred Stock
C - Conversion -52.690 0 -100,00
2018-10-24 2018-10-22 4 PHAS PhaseBio Pharmaceuticals Inc
Series C-1 Preferred Stock
S - Sale -994 40.420 -2,40 5,00 -4.970 202.100
2018-10-24 2018-10-22 4 PHAS PhaseBio Pharmaceuticals Inc
Series C-1 Preferred Stock
M - Exercise 41.414 41.414 0,12 4.970 4.970
2018-10-24 2018-10-22 4 PHAS PhaseBio Pharmaceuticals Inc
Warrants to Purchase Series C-1 Preferred Stock
M - Exercise -41.414 0 -100,00
2018-10-24 2018-10-22 4 PHAS PhaseBio Pharmaceuticals Inc
Series C-1 Preferred Stock
S - Sale -104 13.558 -0,76 5,00 -520 67.790
2018-10-24 2018-10-22 4 PHAS PhaseBio Pharmaceuticals Inc
Series C-1 Preferred Stock
M - Exercise 4.309 13.662 46,07 0,12 517 1.639
2018-10-24 2018-10-22 4 PHAS PhaseBio Pharmaceuticals Inc
Warrants to Purchase Series C-1 Preferred Stock
M - Exercise -4.309 0 -100,00
2018-10-24 2018-10-22 4 PHAS PhaseBio Pharmaceuticals Inc
Series C-1 Preferred Stock
S - Sale -1.139 149.320 -0,76 5,00 -5.695 746.600
2018-10-24 2018-10-22 4 PHAS PhaseBio Pharmaceuticals Inc
Series C-1 Preferred Stock
M - Exercise 47.458 150.459 46,08 0,12 5.695 18.055
2018-10-24 2018-10-22 4 PHAS PhaseBio Pharmaceuticals Inc
Warrants to Purchase Series C-1 Preferred Stock
M - Exercise -47.458 0 -100,00
2018-10-24 2018-10-22 4 PHAS PhaseBio Pharmaceuticals Inc
Series B Preferred Stock
S - Sale -42 94.874 -0,04 5,00 -210 474.370
2018-10-24 2018-10-22 4 PHAS PhaseBio Pharmaceuticals Inc
Series B Preferred Stock
M - Exercise 1.731 94.916 1,86 0,12 208 11.390
2018-10-24 2018-10-22 4 PHAS PhaseBio Pharmaceuticals Inc
Warrants to Purchase Series B Preferred Stock
M - Exercise -1.731 0 -100,00
2018-10-24 2018-10-22 4 PHAS PhaseBio Pharmaceuticals Inc
Series B Preferred Stock
S - Sale -458 1.044.764 -0,04 5,00 -2.290 5.223.820
2018-10-24 2018-10-22 4 PHAS PhaseBio Pharmaceuticals Inc
Series B Preferred Stock
M - Exercise 19.061 1.045.222 1,86 0,12 2.287 125.427
2018-10-24 2018-10-22 4 PHAS PhaseBio Pharmaceuticals Inc
Warrants to Purchase Series B Preferred Stock
M - Exercise -19.061 0 -100,00
2018-10-24 2018-10-22 4 PHAS PhaseBio Pharmaceuticals Inc
Common Stock
P - Purchase 150.000 416.481 56,29 5,00 750.000 2.082.405
2018-10-24 2018-10-22 4 PHAS PhaseBio Pharmaceuticals Inc
Common Stock
C - Conversion 266.481 266.481
2018-10-24 2018-10-22 4 PHAS PhaseBio Pharmaceuticals Inc
Common Stock
C - Conversion 4.846 4.846
2018-10-24 2018-10-22 4 PHAS PhaseBio Pharmaceuticals Inc
Common Stock
P - Purchase 12.487 163.099 8,29 5,00 62.435 815.495
2018-10-24 2018-10-22 4 PHAS PhaseBio Pharmaceuticals Inc
Common Stock
C - Conversion 150.612 150.612
2018-10-24 2018-10-22 4 PHAS PhaseBio Pharmaceuticals Inc
Common Stock
P - Purchase 137.513 1.820.933 8,17 5,00 687.565 9.104.665
2018-10-24 2018-10-22 4 PHAS PhaseBio Pharmaceuticals Inc
Common Stock
C - Conversion 1.683.420 1.683.420
2018-10-24 2018-10-22 4 PHAS PhaseBio Pharmaceuticals Inc
Common Stock
C - Conversion 52.690 52.690
2018-10-17 3 PHAS PhaseBio Pharmaceuticals Inc
Common Stock
23.598
2018-10-17 3 PHAS PhaseBio Pharmaceuticals Inc
Common Stock
23.598
2018-10-17 3 PHAS PhaseBio Pharmaceuticals Inc
Common Stock
23.598
2018-06-21 2018-06-20 4 CLSD Clearside Biomedical, Inc.
Stock Option (right to buy)
A - Award 11.250 11.250
2018-06-01 2018-05-30 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale -41.710 3.237.711 -1,27 48,00 -2.002.080 155.410.128
2018-06-01 2018-05-30 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale -758.290 3.279.421 -18,78 48,00 -36.397.920 157.412.208
2018-05-23 2018-05-23 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale -26 4.037.711 0,00 50,50 -1.313 203.904.406
2018-05-23 2018-05-23 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale -474 4.037.737 -0,01 50,50 -23.937 203.905.718
2018-05-23 2018-05-22 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale -308 4.038.211 -0,01 50,69 -15.611 204.677.128
2018-05-23 2018-05-22 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale -5.592 4.038.519 -0,14 50,86 -284.405 205.396.249
2018-05-23 2018-05-21 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale -26 4.044.111 0,00 52,13 -1.355 210.819.506
2018-05-23 2018-05-21 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale -474 4.044.137 -0,01 52,13 -24.710 210.820.862
2018-05-23 2018-05-21 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale -1.595 4.044.611 -0,04 51,06 -81.439 206.513.389
2018-05-23 2018-05-21 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale -29.005 4.046.206 -0,71 51,16 -1.483.907 207.005.517
2018-05-21 2018-05-18 4 CLSD Clearside Biomedical, Inc.
Common Stock
S - Sale -61.139 3.466.394 -1,73 13,16 -804.589 45.617.745
2018-05-21 2018-05-17 4 CLSD Clearside Biomedical, Inc.
Common Stock
S - Sale -100.000 3.527.533 -2,76 13,03 -1.303.000 45.963.755
2018-03-23 2018-03-23 4 CLSD Clearside Biomedical, Inc.
Common Stock
S - Sale -5.231 3.627.533 -0,14 12,02 -62.877 43.602.947
2018-03-23 2018-03-22 4 CLSD Clearside Biomedical, Inc.
Common Stock
S - Sale -33.630 3.632.764 -0,92 12,07 -405.914 43.847.461
2018-03-23 2018-03-21 4 CLSD Clearside Biomedical, Inc.
Common Stock
S - Sale -100.000 3.666.394 -2,66 12,27 -1.227.000 44.986.654
2017-12-07 2017-12-07 4 CLSD Clearside Biomedical, Inc.
Common Stock
S - Sale X -5.000 3.766.394 -0,13 6,13 -30.650 23.087.995
2017-12-07 2017-12-06 4 CLSD Clearside Biomedical, Inc.
Common Stock
S - Sale X -15.000 3.771.394 -0,40 6,09 -91.350 22.967.789
2017-12-07 2017-12-05 4 CLSD Clearside Biomedical, Inc.
Common Stock
S - Sale X -15.000 3.786.394 -0,39 6,37 -95.550 24.119.330
2017-12-04 2017-11-30 4 GTHX G1 Therapeutics, Inc.
Common Stock
J - Other 995 4.075.211 0,02
2017-12-04 2017-11-30 4 GTHX G1 Therapeutics, Inc.
Common Stock
J - Other -99.513 4.074.216 -2,38
2017-11-16 2017-11-16 4 CLSD Clearside Biomedical, Inc.
Common Stock
S - Sale X -5.000 3.801.394 -0,13 6,99 -34.950 26.571.744
2017-11-16 2017-11-15 4 CLSD Clearside Biomedical, Inc.
Common Stock
S - Sale X -15.000 3.806.394 -0,39 6,99 -104.850 26.606.694
2017-11-16 2017-11-14 4 CLSD Clearside Biomedical, Inc.
Common Stock
S - Sale X -15.000 3.821.394 -0,39 7,02 -105.300 26.826.186
2017-10-05 2017-10-05 4 CLSD Clearside Biomedical, Inc.
Common Stock
S - Sale X -6.000 3.836.394 -0,16 8,34 -50.040 31.995.526
2017-10-05 2017-10-04 4 CLSD Clearside Biomedical, Inc.
Common Stock
S - Sale X -14.000 3.842.394 -0,36 8,59 -120.260 33.006.164
2017-10-05 2017-10-03 4 CLSD Clearside Biomedical, Inc.
Common Stock
S - Sale X -15.000 3.856.394 -0,39 8,64 -129.600 33.319.244
2017-09-15 2017-09-15 4 CLSD Clearside Biomedical, Inc.
Common Stock
S - Sale X -10.000 3.871.394 -0,26 7,54 -75.400 29.190.311
2017-09-15 2017-09-14 4 CLSD Clearside Biomedical, Inc.
Common Stock
S - Sale X -6.000 3.881.394 -0,15 7,52 -45.120 29.188.083
2017-09-15 2017-09-13 4 CLSD Clearside Biomedical, Inc.
Common Stock
S - Sale X -8.500 3.887.394 -0,22 7,49 -63.665 29.116.581
2017-08-09 2017-08-09 4 CLSD Clearside Biomedical, Inc.
Common Stock
S - Sale X -15.000 3.895.894 -0,38 7,30 -109.500 28.440.026
2017-08-09 2017-08-08 4 CLSD Clearside Biomedical, Inc.
Common Stock
S - Sale X -5.000 3.910.894 -0,13 7,98 -39.900 31.208.934
2017-08-09 2017-08-07 4 CLSD Clearside Biomedical, Inc.
Common Stock
S - Sale X -4.500 3.915.894 -0,11 8,02 -36.090 31.405.470
2017-07-05 2017-06-30 4 CLSD Clearside Biomedical, Inc.
Stock Option (right to buy)
A - Award 2.632 2.632
2017-06-23 2017-06-22 4 CLSD Clearside Biomedical, Inc.
Stock Option (right to buy)
A - Award 8.618 8.618
2017-05-24 2017-05-22 4 GTHX G1 Therapeutics, Inc.
Series C Preferred Stock
C - Conversion -1.009.693 0 -100,00
2017-05-24 2017-05-22 4 GTHX G1 Therapeutics, Inc.
Series B Preferred Stock
C - Conversion -2.584.959 0 -100,00
2017-05-24 2017-05-22 4 GTHX G1 Therapeutics, Inc.
Series A Preferred Stock
C - Conversion -6.568.527 0 -100,00
2017-05-24 2017-05-22 4 GTHX G1 Therapeutics, Inc.
Series 1 Preferred Stock
C - Conversion -1.318.681 0 -100,00
2017-05-24 2017-05-22 4 GTHX G1 Therapeutics, Inc.
Common Stock
P - Purchase 133.333 3.861.797 3,58 15,00 1.999.995 57.926.955
2017-05-24 2017-05-22 4 GTHX G1 Therapeutics, Inc.
Common Stock
C - Conversion 99.513 99.513
2017-05-24 2017-05-22 4 GTHX G1 Therapeutics, Inc.
Common Stock
C - Conversion 212.419 212.419
2017-05-24 2017-05-22 4 GTHX G1 Therapeutics, Inc.
Common Stock
C - Conversion 3.728.464 3.728.464
2017-05-19 2017-05-19 4 CLSD Clearside Biomedical, Inc.
Common Stock
S - Sale X -15.000 3.920.394 -0,38 8,31 -124.650 32.578.474
2017-05-19 2017-05-18 4 CLSD Clearside Biomedical, Inc.
Common Stock
S - Sale X -9.000 3.935.394 -0,23 8,44 -75.960 33.214.725
2017-05-17 2017-05-17 4 CLSD Clearside Biomedical, Inc.
Common Stock
S - Sale X -19.000 3.944.394 -0,48 8,39 -159.410 33.093.466
2017-05-17 2017-05-16 4 CLSD Clearside Biomedical, Inc.
Common Stock
S - Sale X -9.544 3.963.394 -0,24 8,61 -82.174 34.124.822
2017-05-17 2017-05-15 4 CLSD Clearside Biomedical, Inc.
Common Stock
S - Sale X -15.941 3.972.938 -0,40 8,94 -142.513 35.518.066
2017-05-17 3 GTHX G1 Therapeutics, Inc.
Common Stock
413.041
2017-05-17 3 GTHX G1 Therapeutics, Inc.
Common Stock
226.301
2017-05-17 3 GTHX G1 Therapeutics, Inc.
Common Stock
413.041
2017-05-17 3 GTHX G1 Therapeutics, Inc.
Common Stock
226.301
2017-04-19 2017-04-19 4 CLSD Clearside Biomedical, Inc.
Common Stock
S - Sale X -2.030 3.988.879 -0,05 7,37 -14.961 29.398.038
2017-04-19 2017-04-18 4 CLSD Clearside Biomedical, Inc.
Common Stock
S - Sale X -44.455 3.990.909 -1,10 7,48 -332.523 29.851.999
2017-04-19 2017-04-17 4 CLSD Clearside Biomedical, Inc.
Common Stock
S - Sale X -22.000 4.035.364 -0,54 7,43 -163.460 29.982.755
2017-03-17 2017-03-16 4 CLSD Clearside Biomedical, Inc.
Common Stock
S - Sale X -21.485 4.057.364 -0,53 6,77 -145.453 27.468.354
2017-03-17 2017-03-15 4 CLSD Clearside Biomedical, Inc.
Common Stock
S - Sale X -47.000 4.078.849 -1,14 6,47 -304.090 26.390.153
2017-02-22 2017-02-22 4 CLSD Clearside Biomedical, Inc.
Common Stock
S - Sale X -2.000 4.125.849 -0,05 7,49 -14.980 30.902.609
2017-02-22 2017-02-21 4 CLSD Clearside Biomedical, Inc.
Common Stock
S - Sale X -25.000 4.127.849 -0,60 7,55 -188.750 31.165.260
2017-02-17 2017-02-17 4 CLSD Clearside Biomedical, Inc.
Common Stock
S - Sale X -10.000 4.152.849 -0,24 7,54 -75.400 31.312.481
2017-02-17 2017-02-16 4 CLSD Clearside Biomedical, Inc.
Common Stock
S - Sale X -14.000 4.162.849 -0,34 7,58 -106.120 31.554.395
2017-02-17 2017-02-15 4 CLSD Clearside Biomedical, Inc.
Common Stock
S - Sale X -17.485 4.176.849 -0,42 7,64 -133.585 31.911.126
2017-01-20 2017-01-20 4 CLSD Clearside Biomedical, Inc.
Common Stock
S - Sale X -8.000 4.194.334 -0,19 7,77 -62.160 32.589.975
2017-01-20 2017-01-19 4 CLSD Clearside Biomedical, Inc.
Common Stock
S - Sale X -15.485 4.202.334 -0,37 8,23 -127.442 34.585.209
2017-01-20 2017-01-18 4 CLSD Clearside Biomedical, Inc.
Common Stock
S - Sale X -25.000 4.217.819 -0,59 8,64 -216.000 36.441.956
2017-01-20 2017-01-17 4 CLSD Clearside Biomedical, Inc.
Common Stock
S - Sale X -20.000 4.242.819 -0,47 8,92 -178.400 37.845.945
2017-01-19 2017-01-19 4 CLSD Clearside Biomedical, Inc.
Common Stock
S - Sale -7.592 2.060.514 -0,37 8,22 -62.406 16.937.425
2017-01-19 2017-01-18 4 CLSD Clearside Biomedical, Inc.
Common Stock
S - Sale -12.258 2.068.106 -0,59 8,64 -105.909 17.868.436
2017-01-19 2017-01-17 4 CLSD Clearside Biomedical, Inc.
Common Stock
S - Sale -9.806 2.080.364 -0,47 8,92 -87.470 18.556.847
2017-01-19 2017-01-19 4 CLSD Clearside Biomedical, Inc.
Common Stock
S - Sale -6.478 1.757.719 -0,37 8,22 -53.249 14.448.450
2017-01-19 2017-01-18 4 CLSD Clearside Biomedical, Inc.
Common Stock
S - Sale -10.457 1.764.197 -0,59 8,64 -90.348 15.242.662
2017-01-19 2017-01-17 4 CLSD Clearside Biomedical, Inc.
Common Stock
S - Sale -8.366 1.774.654 -0,47 8,92 -74.625 15.829.914
2016-06-07 2016-06-07 4 CLSD Clearside Biomedical, Inc.
Warrant to Purchase Common Stock (right to buy)
X - Other -21.705 0 -100,00
2016-06-07 2016-06-07 4 CLSD Clearside Biomedical, Inc.
Series C Preferred Stock
C - Conversion -337.897 0 -100,00
2016-06-07 2016-06-07 4 CLSD Clearside Biomedical, Inc.
Series B Preferred Stock
C - Conversion -432.941 0 -100,00
2016-06-07 2016-06-07 4 CLSD Clearside Biomedical, Inc.
Series A-1 Preferred Stock
C - Conversion -689.388 0 -100,00
2016-06-07 2016-06-07 4 CLSD Clearside Biomedical, Inc.
Series A Preferred Stock
C - Conversion -2.035.908 0 -100,00
2016-06-07 2016-06-07 4 CLSD Clearside Biomedical, Inc.
Common Stock
P - Purchase 414.286 2.090.170 24,72 7,00 2.900.002 14.631.190
2016-06-07 2016-06-07 4 CLSD Clearside Biomedical, Inc.
Common Stock
S - Sale -69 1.675.884 0,00 7,00 -483 11.731.188
2016-06-07 2016-06-07 4 CLSD Clearside Biomedical, Inc.
Common Stock
X - Other 21.705 1.675.953 1,31 0,02 478 36.871
2016-06-07 2016-06-07 4 CLSD Clearside Biomedical, Inc.
Common Stock
C - Conversion 1.598.223 1.654.248 2.852,70
2016-06-07 2016-06-07 4 CLSD Clearside Biomedical, Inc.
Warrant to Purchase Common Stock (right to buy)
X - Other -1.805 0 -100,00
2016-06-07 2016-06-07 4 CLSD Clearside Biomedical, Inc.
Warrant to Purchase Common Stock (right to buy)
X - Other -19.900 0 -100,00
2016-06-07 2016-06-07 4 CLSD Clearside Biomedical, Inc.
Series C Preferred Stock
C - Conversion -337.898 0 -100,00
2016-06-07 2016-06-07 4 CLSD Clearside Biomedical, Inc.
Series B Preferred Stock
C - Conversion -432.940 0 -100,00
2016-06-07 2016-06-07 4 CLSD Clearside Biomedical, Inc.
Series A-1 Preferred Stock
C - Conversion -689.388 0 -100,00
2016-06-07 2016-06-07 4 CLSD Clearside Biomedical, Inc.
Series A Preferred Stock
C - Conversion -2.035.907 0 -100,00
2016-06-07 2016-06-07 4 CLSD Clearside Biomedical, Inc.
Common Stock
P - Purchase 107.142 1.783.020 6,39 7,00 749.994 12.481.140
2016-06-07 2016-06-07 4 CLSD Clearside Biomedical, Inc.
Common Stock
S - Sale -69 1.675.878 0,00 7,00 -483 11.731.146
2016-06-07 2016-06-07 4 CLSD Clearside Biomedical, Inc.
Common Stock
X - Other 21.705 1.675.947 1,31 0,02 478 36.871
2016-06-07 2016-06-07 4 CLSD Clearside Biomedical, Inc.
Common Stock
C - Conversion 1.598.219 1.654.242 2.852,79
2016-06-07 2016-06-07 4 CLSD Clearside Biomedical, Inc.
Warrant to Purchase Common Stock (right to buy)
X - Other -21.705 0 -100,00
2016-06-07 2016-06-07 4 CLSD Clearside Biomedical, Inc.
Warrant to Purchase Common Stock (right to buy)
X - Other -1.805 0 -100,00
2016-06-07 2016-06-07 4 CLSD Clearside Biomedical, Inc.
Warrant to Purchase Common Stock (right to buy)
X - Other -19.900 0 -100,00
2016-06-07 2016-06-07 4 CLSD Clearside Biomedical, Inc.
Series C Preferred Stock
C - Conversion -675.795 0 -100,00
2016-06-07 2016-06-07 4 CLSD Clearside Biomedical, Inc.
Series B Preferred Stock
C - Conversion -865.881 0 -100,00
2016-06-07 2016-06-07 4 CLSD Clearside Biomedical, Inc.
Series A-1 Preferred Stock
C - Conversion -1.654.531 0 -100,00
2016-06-07 2016-06-07 4 CLSD Clearside Biomedical, Inc.
Series A Preferred Stock
C - Conversion -4.071.815 0 -100,00
2016-06-07 2016-06-07 4 CLSD Clearside Biomedical, Inc.
Common Stock
P - Purchase 785.714 4.262.819 22,60 7,00 5.499.998 29.839.733
2016-06-07 2016-06-07 4 CLSD Clearside Biomedical, Inc.
Common Stock
S - Sale -138 3.477.105 0,00 7,00 -966 24.339.735
2016-06-07 2016-06-07 4 CLSD Clearside Biomedical, Inc.
Common Stock
X - Other 43.410 3.477.243 1,26 0,02 955 76.499
2016-06-07 2016-06-07 4 CLSD Clearside Biomedical, Inc.
Common Stock
C - Conversion 3.321.785 3.433.833 2.964,61
2016-06-01 3 CLSD Clearside Biomedical, Inc.
Common Stock
224.096
2016-06-01 3 CLSD Clearside Biomedical, Inc.
Common Stock
224.096
2016-06-01 3 CLSD Clearside Biomedical, Inc.
Common Stock
112.050
2016-06-01 3 CLSD Clearside Biomedical, Inc.
Common Stock
112.050
2016-06-01 3 CLSD Clearside Biomedical, Inc.
Common Stock
112.050
2016-06-01 3 CLSD Clearside Biomedical, Inc.
Common Stock
112.050
2016-06-01 3 CLSD Clearside Biomedical, Inc.
Common Stock
112.050
2016-06-01 3 CLSD Clearside Biomedical, Inc.
Common Stock
112.050
2016-06-01 3 CLSD Clearside Biomedical, Inc.
Common Stock
112.050
2016-06-01 3 CLSD Clearside Biomedical, Inc.
Common Stock
112.050
2016-06-01 3 CLSD Clearside Biomedical, Inc.
Common Stock
112.046
2016-06-01 3 CLSD Clearside Biomedical, Inc.
Common Stock
112.046
2016-06-01 3 CLSD Clearside Biomedical, Inc.
Common Stock
112.046
2016-06-01 3 CLSD Clearside Biomedical, Inc.
Common Stock
112.046
2016-06-01 3 CLSD Clearside Biomedical, Inc.
Common Stock
112.046
2016-06-01 3 CLSD Clearside Biomedical, Inc.
Common Stock
112.046
2016-06-01 3 CLSD Clearside Biomedical, Inc.
Common Stock
112.046
2016-06-01 3 CLSD Clearside Biomedical, Inc.
Common Stock
112.046
2016-06-01 3 CLSD Clearside Biomedical, Inc.
Common Stock
112.046
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)